124 related articles for article (PubMed ID: 1871832)
1. Imaging and quantitation of renal transplant rejection in the rat by in vivo use of 111In labelled antilymphocyte and anti-class I and II major histocompatibility complex monoclonal antibodies.
Loutfi I; Batchelor JR; Lavender JP
Transplant Proc; 1991 Aug; 23(4):2143-6. PubMed ID: 1871832
[No Abstract] [Full Text] [Related]
2. Evidence for processing of WAG antigens by the RT1-D class II MHC molecules of PVG rats during kidney allograft rejection.
Priestley CA; Spencer SS; Sawyer GJ; Fabre JW
Transplant Proc; 1990 Aug; 22(4):1947-8. PubMed ID: 2389491
[No Abstract] [Full Text] [Related]
3. Elucidation of key peptide determinants involved in an indirect T-cell allorecognition pathway of rat kidney allograft rejection.
Benham AM; Fabre JW
Transplant Proc; 1995 Feb; 27(1):547-8. PubMed ID: 7879093
[No Abstract] [Full Text] [Related]
4. The role of CD4+ and CD8+ T cells in rejection of class I MHC disparate renal allografts.
Bradley JA; Gracie JA; Porteous C; Bolton EM
Transplant Proc; 1991 Feb; 23(1 Pt 1):266-7. PubMed ID: 1899304
[No Abstract] [Full Text] [Related]
5. Transplantation of rat kidneys following perfusion with anti-Ia monoclonal antibody.
Jablonski P; Kraft N; Howden BO; Thomson NM; Atkins RC; Marshall VC
Transplant Proc; 1989 Feb; 21(1 Pt 1):1123-4. PubMed ID: 2650073
[No Abstract] [Full Text] [Related]
6. Hyperacute rejection from antibody against class II HLA antigens.
Ghasemian SR; Light JA; Sasaki TA; Barhyte DY
Clin Transplant; 1998 Dec; 12(6):569-71. PubMed ID: 9850452
[TBL] [Abstract][Full Text] [Related]
7. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
[TBL] [Abstract][Full Text] [Related]
8. Role of interferon alpha in allograft rejection.
Benizri EJ; Gugenheim J; Bernard G; Tovey MG
Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
[No Abstract] [Full Text] [Related]
9. Posttransplant immune monitoring of anti-HLA antibody.
Kerman RH; Katz SM; Van Buren CT; Ruth J; McKissick E; Rasmussen S; Kahan BD
Transplant Proc; 2001; 33(1-2):402. PubMed ID: 11266882
[No Abstract] [Full Text] [Related]
10. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
[No Abstract] [Full Text] [Related]
11. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
Süsal C; Opelz G
Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
[TBL] [Abstract][Full Text] [Related]
12. Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome.
Piazza A; Poggi E; Borrelli L; Valeri M; Buonomo O; Servetti S; Adorno D; Casciani CU
Transplant Proc; 2001; 33(1-2):478-80. PubMed ID: 11266917
[No Abstract] [Full Text] [Related]
13. Suppression of renal allograft rejection in the rat using purified plasma membrane and endoplasmic reticulum preparation expressing donor class I major histocompatibility complex antigen.
Foster S; Wood KJ; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):469. PubMed ID: 3274808
[No Abstract] [Full Text] [Related]
14. Lack of dependence of dendritic cell replacement in accepted rat renal allograft recipients upon a class II MHC disparity.
Olivier WA; Sanfilippo F
Transplantation; 1991 Jun; 51(6):1315-7. PubMed ID: 2048211
[No Abstract] [Full Text] [Related]
15. Renal target structures in acute allograft rejection.
Leszczynski D; Laszczynska M; Halttunen J
Transplant Proc; 1987 Feb; 19(1 Pt 1):378. PubMed ID: 3079159
[No Abstract] [Full Text] [Related]
16. Combined transplantation of islets and kidney: immunogenetic analysis in the rat.
Hiller WF; Vogt P; Steiniger B; Klempnauer J
Transplant Proc; 1993 Feb; 25(1 Pt 2):976-7. PubMed ID: 8442287
[No Abstract] [Full Text] [Related]
17. Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
Kriaa F; Hiesse C; Alard P; Lantz O; Noury J; Charpentier B; Bazin H
Transplant Proc; 1993 Feb; 25(1 Pt 1):817-9. PubMed ID: 8438496
[No Abstract] [Full Text] [Related]
18. Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection.
von Willebrand E; Häyry P
Transplant Proc; 1987 Feb; 19(1 Pt 2):1644-5. PubMed ID: 3079030
[No Abstract] [Full Text] [Related]
19. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against MICA antigens and kidney-transplant rejection.
Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
